Clinical Trial Update: Telithromycin in Acute Exacerbation of Chronic Bronchitis [Phase 4]

View source ↗

Summary

Phase 4 trial of Telithromycin for acute exacerbation of chronic bronchitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Exacerbation of Chronic Bronchitis

Drugs mentioned

• Telithromycin (Ketek) (Telithromycin)

Snippet

Sponsor: Sanofi | Conditions: Bronchitis, Chronic | Phase 4 | Status: TERMINATED